CDKN2A and gallbladder cancer: The positive expression rate of P16 in the high differentiation (86.67%) was significantly higher than that in the middle differentiation (40%) and poor differentiation (28.57%) (P < 0.05), indicating that the positive expression of P16 protein in the gallbladder cancer tissue was related to the degree of tissue differentiation.